TLX Homeodomain Oncogenes Mediate T Cell Maturation Arrest in T-ALL via Interaction with ETS1 and Suppression of TCR alpha Gene Expression

  • S Dadi
  • , S Le Noir
  • , D Payet-Bornet
  • , L Lhermitte
  • , J Zacarias-Cabeza
  • , J Bergeron
  • , P Villarese
  • , E Vachez
  • , Wim Dik
  • , C Millien
  • , I Radford
  • , E Verhoeyen
  • , FL Cosset
  • , A Petit
  • , N Ifrah
  • , H Dombret
  • , O Hermine
  • , S Spicuglia
  • , Ton Langerak
  • , EA Macintyre
  • B Nadel, P Ferrier, V Asnafi

Research output: Contribution to journalArticleAcademicpeer-review

81 Citations (Scopus)

Abstract

Acute lymphoblastic leukemias (ALLs) are characterized by multistep oncogenic processes leading to cell-differentiation arrest and proliferation. Specific abrogation of maturation blockage constitutes a promising therapeutic option in cancer, which requires precise understanding of the underlying molecular mechanisms. We show that the cortical thymic maturation arrest in T-lineage ALLs that overexpress TLX1 or TLX3 is due to binding of TLX1/TLX3 to ETS1, leading to repression of T cell receptor (TCR) alpha enhanceosome activity and blocked TCR-J alpha rearrangement. TLX1/TLX3 abrogation or enforced TCR alpha beta expression leads to TCR alpha rearrangement and apoptosis. Importantly, the autoextinction of clones carrying TCR alpha-driven TLX1 expression supports TLX "addiction" in TLX-positive leukemias and provides further rationale for targeted therapy based on disruption of TLX1/TLX3.
Original languageUndefined/Unknown
Pages (from-to)563-576
Number of pages14
JournalCancer Cell
Volume21
Issue number4
DOIs
Publication statusPublished - 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research programs

  • EMC MM-02-72-02
  • EMC MM-02-72-03

Cite this